Table: begin end state 1 5 non-cytoplasmic 6 33 transmembrane 34 51 cytoplasmic 52 73 transmembrane 74 101 non-cytoplasmic 102 125 transmembrane 126 136 cytoplasmic 137 157 transmembrane 158 169 non-cytoplasmic 170 196 transmembrane 197 215 cytoplasmic 216 239 transmembrane 240 244 non-cytoplasmic 245 263 transmembrane 264 274 cytoplasmic 275 296 transmembrane 297 308 non-cytoplasmic 309 333 transmembrane 334 337 cytoplasmic 338 356 transmembrane 357 361 non-cytoplasmic 362 383 transmembrane 384 402 cytoplasmic 403 425 transmembrane 426 430 non-cytoplasmic
Input: >WP_086508865.1 NCBI__GCF_002151265.1:WP_086508865.1 MEVFVIMFVSLIVLLMLGVPVAFAMIASSALVLGYTRGFDAIPMEMISQRMLYGVNSFTL LAIPAFLLIGRLMNSAGISDRVFDIARTMVGHLKGGLGHVNVVASMLFAGMSGSAVADAG GLGALEIKAMEDDGYPTGFSAAVTASSATIGPIIPPSIPAVIYGALANASIAAIFLASII PGLIMGLGLMAMVAIISHRRGFPTRARAKFSEFLAALWRGLLPMLTPLIIIVGILSGIFT PTEASVVALLYCLIIAFLVYRSISFFEFLNILRATAIDTAVLLFIIAGSALYSWVLARYQ VTSLVADFLLTTVTSPLGVLLLLALFILLIGLFIDSVPALFLLTPLLVPVVTQYGIDPVH FGVVMIFTLMIGLITPPVGTVLFTIQKITAMPFGGLVREILPFYIPLIIVLLGIILFPSI VMFLPNLIMN
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server